Remember about genetech with Insulin and Trastuzumab. I think SPL could reach this level, big boys would be playing on. At last SPL would give up, and come to one of the big boys team. But too eager to see phase 1 results, please dont let me down. From my clinical experience, the hair loss and vomiting using docetaxel is very common, nearly 90% patients, and if true DEP™ docetaxel is amazing.
In case DEP™ docetaxel is successful, next step is Her2-DEP docetaxel, who know could replace the breast cancer resection at first-line choice. That will change the whole oncology.
The Pipeline, page-21
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
-0.005(4.76%) |
Mkt cap ! $41.23M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 10.0¢ | $3.399K | 33.37K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 33777 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 115551 | 4 |
View Market Depth
| Last trade - 14.07pm 12/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |